Genprex IPO-lister over NASDAQ- Genterapi Lungekreftbehandling blir finansiertBlogg
RodTurner's blog Prospectus. Genprex has completed its S-1 IPO offering. Their IPO is now listed and trading on the Nasdaq Exchange under the ticker NASDAQ: GNPX. The offering raised $6.5 million at $5/share ...